AI assistant
Sending…
Mawson Infrastructure Group Inc. — Director's Dealing 2018
Jan 16, 2018
35202_dirs_2018-01-16_6726fae2-d2f4-47a4-973d-698f922f5c64.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-01-09
Reporting Person: Zarachia Yaakov (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-09 | Common Stock, par value $0.001 per share | P | 9841 | $0.105 | Acquired | 12330674 | Direct |
| 2018-01-10 | Common Stock, par value $0.001 per share | P | 4000 | $0.150 | Acquired | 12334674 | Direct |
| 2018-01-10 | Common Stock, par value $0.001 per share | P | 9281 | $0.142 | Acquired | 12343892 | Direct |
More from Mawson Infrastructure Group Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 18
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 6
Proxy Solicitation & Information Statement
2026
Feb 4
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30